Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsu

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3119

Patent

active

044230753

ABSTRACT:
Disclosed are new methods of using 5-fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acet ic acid or a therapeutically acceptable salt thereof with an organic or inorganic base for the treatment of complications associated with diabetes mellitus. The compound inhibits lens aldose reductase in a diabetic mammal.

REFERENCES:
patent: 3647858 (1972-03-01), Hinkley et al.
patent: 3654349 (1972-04-01), Shen et al.
patent: 3821383 (1974-06-01), Sestanj et al.
"Physicians Desk Reference", 34th ed. Medical Economics Co., Ordell, N.J., pp. 1147-1149.
J. R. Ryan et al., Clin. Pharmacol. Ther., 21, 231 (1977).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsu will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-947297

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.